These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15402779)

  • 1. [Results of roentgentherapy on skeletal breast cancer metastases].
    SANTAGATI F
    Radiol Clin; 1950 Jan; 19(1):51-7. PubMed ID: 15402779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of roentgentherapy in skeletal metastases in breast cancer].
    SANTAGATI F
    J Radiol Electrol Arch Electr Medicale; 1949; 30(5-6):332. PubMed ID: 18134416
    [No Abstract]   [Full Text] [Related]  

  • 3. [Skeletal metastases of carcinoma of the breast].
    VENTURI R
    Chir Organi Mov; 1960; 49():399-427. PubMed ID: 13780739
    [No Abstract]   [Full Text] [Related]  

  • 4. Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.
    Cremers SC; Papapoulos SE; Gelderblom H; Seynaeve C; den Hartigh J; Vermeij P; van der Rijt CC; van Zuylen L
    J Bone Miner Res; 2005 Sep; 20(9):1543-7. PubMed ID: 16059626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone metastases in cancer of the breast].
    SAMATUGIN LI
    Zdravookhr Beloruss; 1962 Aug; 8():39-40. PubMed ID: 14496571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cancer of the breast and significant bone metastases].
    LAHBABI M
    Maroc Med; 1959 Jun; 38():877-8. PubMed ID: 14413462
    [No Abstract]   [Full Text] [Related]  

  • 7. Roentgentherapy of benign giant-cell tumor of bone.
    BUSCHKE F; CANTRIL ST
    Cancer; 1949 Mar; 2(2):293-315. PubMed ID: 18115906
    [No Abstract]   [Full Text] [Related]  

  • 8. [Roentgen therapy of metastases of cancer of the breast into the ossesous system].
    LARIOSHCHENKO TG
    Vopr Onkol; 1960; 6():94-8. PubMed ID: 14414201
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the clinical aspects of metastases of cancer of the breast into the osseous system].
    ROZIN DL
    Vopr Onkol; 1960; 6():98-105. PubMed ID: 14439813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is preoperative bone scintigraphy in early stage of breast cancer T1N0 indicated and meaningful?].
    Žaloudík J; Skovajsová M; Česlarová K; Bieberová L; Hussarová L; Zimovjanová M; Petruželka L
    Klin Onkol; 2013; 26(6):443-7. PubMed ID: 24320594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Failure of androgens for bone metastases from breast cancer].
    FAULONG L; KAPLAN S
    Rev Rhum Mal Osteoartic; 1949 Oct; 16(10):528-30. PubMed ID: 15407407
    [No Abstract]   [Full Text] [Related]  

  • 12. [The roentgenological picture of skeletal metastases of mammary cancer during hormonal treatment].
    den HERDER BA; BOSBOOM BJ; GERBRANDY J
    Jaarb K Ned Bot Ver; 1959; 9():57-8. PubMed ID: 13713563
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parathyroidectomy in osseous metastases of cancer of the breast].
    TRIFFAUD A
    Mars Chir; 1950; 2(1):145-6. PubMed ID: 15416266
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metastases of breast cancer to bones and lungs and their responses to adrenalectomy].
    TYPOVSKY K; BRUCKNER L; DOLECEK R; KOZIEL M; STEPANEK V
    Cesk Rentgenol; 1962 Apr; 16():100-5. PubMed ID: 13923367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of Talairach's method in a diabetic with cancer of the breast with osseous metastases].
    DEROT M; RATHERY M; ROY JL
    Bull Mem Soc Med Hop Paris; 1960 Jun 8-Jul 24; 76():860-4. PubMed ID: 13816063
    [No Abstract]   [Full Text] [Related]  

  • 16. 18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
    Brito AE; Santos A; Sasse AD; Cabello C; Oliveira P; Mosci C; Souza T; Amorim B; Lima M; Ramos CD; Etchebehere E
    Oncotarget; 2017 May; 8(22):36001-36011. PubMed ID: 28415595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report on hormone therapy of generalized skeletal metastases from breast carcinoma].
    WUTSCHKE J
    Arch Geschwulstforsch; 1959; 14(2):174-83. PubMed ID: 13661881
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.
    Koizumi M; Motegi K; Umeda T
    Ann Nucl Med; 2019 Jul; 33(7):502-511. PubMed ID: 30982124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    Himelstein AL; Foster JC; Khatcheressian JL; Roberts JD; Seisler DK; Novotny PJ; Qin R; Go RS; Grubbs SS; O'Connor T; Velasco MR; Weckstein D; O'Mara A; Loprinzi CL; Shapiro CL
    JAMA; 2017 Jan; 317(1):48-58. PubMed ID: 28030702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal treatment of osseous metastases of breast cancers].
    WEISSENBACH R
    Bull Med; 1950 Apr; 64(8):185-8. PubMed ID: 15411566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.